TD ASSET MANAGEMENT INC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 208 filers reported holding GW PHARMACEUTICALS PLC in Q4 2017. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2020$1,197,000
+18.5%
10,3760.0%0.00%0.0%
Q3 2020$1,010,000
-20.7%
10,3760.0%0.00%
-50.0%
Q2 2020$1,273,000
+40.0%
10,3760.0%0.00%0.0%
Q1 2020$909,000
-16.2%
10,3760.0%0.00%0.0%
Q4 2019$1,085,000
-9.1%
10,3760.0%0.00%0.0%
Q3 2019$1,194,000
-33.9%
10,376
-1.0%
0.00%
-33.3%
Q2 2019$1,806,000
-3.3%
10,476
-5.4%
0.00%0.0%
Q1 2019$1,867,000
+70.0%
11,076
-1.8%
0.00%
+50.0%
Q4 2018$1,098,000
-62.3%
11,276
-33.2%
0.00%
-50.0%
Q3 2018$2,915,000
-9.5%
16,876
-26.9%
0.00%
-20.0%
Q2 2018$3,220,000
+69.1%
23,076
+36.5%
0.01%
+66.7%
Q1 2018$1,904,000
-38.9%
16,900
-28.4%
0.00%
-40.0%
Q4 2017$3,115,000
+27.8%
23,600
-1.7%
0.01%
+25.0%
Q3 2017$2,438,000
+15.5%
24,019
+14.1%
0.00%
+33.3%
Q2 2017$2,110,000
-9.1%
21,043
+9.7%
0.00%
-25.0%
Q1 2017$2,321,000
+53.6%
19,190
+41.9%
0.00%
+33.3%
Q4 2016$1,511,000
-19.9%
13,519
-4.9%
0.00%0.0%
Q3 2016$1,887,000
+353.6%
14,219
+213.1%
0.00%
+200.0%
Q2 2016$416,000
+6.1%
4,542
-31.2%
0.00%0.0%
Q1 2014$392,0006,6000.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2017
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 450,000$55,224,0004.41%
Parkman Healthcare Partners LLC 119,778$14,699,0004.14%
Sio Capital Management, LLC 94,984$11,656,0003.40%
Tamarack Advisers, LP 90,000$11,045,0003.08%
Copernicus Capital Management, LLC 22,000$2,700,0002.96%
Integral Health Asset Management, LLC 75,000$9,204,0002.76%
ETF MANAGERS GROUP, LLC 480,145$58,923,0002.09%
AdvisorShares Investments LLC 29,758$3,652,0001.55%
Redwood Investments, LLC 130,444$16,008,0001.42%
CLOUGH CAPITAL PARTNERS L P 100,746$12,364,0001.21%
View complete list of GW PHARMACEUTICALS PLC shareholders